AMPH

Amphastar Pharmaceuticals Stock Analysis

AI Rating

Fair
  • Quality8/10
  • Growth↓ 0/10
  • Value↓ 4/10
Amphastar Pharmaceuticals sales and earnings growth
AMPH Growth
Low
  • Revenue Y/Y↓ 3.57%
  • EPS Y/Y↓ -41.44%
  • FCF Y/Y↓ -10.01%
Amphastar Pharmaceuticals gross and profit margin trends
AMPH Profitability
Good
  • Gross margin ↑ 47.30%
  • EPS margin↑ 11.00%
  • ROIC 5Y↓ 17.43%
Amphastar Pharmaceuticals net debt vs free cash flow
AMPH Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 3.8
  • Interest coverage↓ 5.0

Amphastar Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks